1 |
Saharkhiz S, Zarepour A, Zarrabi A. A new theranostic pH-responsive niosome formulation for Doxorubicin delivery and bio-imaging against breast cancer. Int J Pharm 2023;:122845. [PMID: 36958608 DOI: 10.1016/j.ijpharm.2023.122845] [Reference Citation Analysis]
|
2 |
Cai X, Fan B, Thang SH, Drummond CJ, Tran N, Zhai J. Paclitaxel-loaded cubosome lipid nanocarriers stabilised with pH and hydrogen peroxide-responsive steric stabilisers as drug delivery vehicles. J Mater Chem B 2023;11:403-14. [PMID: 36511883 DOI: 10.1039/d2tb01530g] [Reference Citation Analysis]
|
3 |
Khan S, Madni A, Shah H, Jan N, Shafiq A, Basit A, Rai N, Ali A, Khan MM. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer. Int J Biol Macromol 2022;222:497-508. [PMID: 36174854 DOI: 10.1016/j.ijbiomac.2022.09.196] [Reference Citation Analysis]
|
4 |
Shafiq A, Madni A, Khan S, Sultana H, Sumaira, Shah H, Khan S, Rehman S, Nawaz M. Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis. Int J Biol Macromol 2022;213:465-77. [PMID: 35661673 DOI: 10.1016/j.ijbiomac.2022.05.192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|